Solutions for CRRT Comparisons March 2009
Transcription
Solutions for CRRT Comparisons March 2009
Solutions for CRRT Comparisons March 2009 Home: Critical Care: Products: Fluids NxStage prepackaged fluids for acute renal care NxStage provides a full range of easy-to-use, convenient and economical sterile dialysate fluids that simplify the delivery of intensive care dialysis. NxStage PureFlow™ prepackaged solutions offer significant advantages: They are available with bicarbonate or lactate buffers, giving you treatment options. NxStage PureFlow Solutions ensure fluid quality, with potential clinical benefits. They meet or exceed AAMI, USP, and European Pharmacopoeia standards. Products are terminally sterilized and pyrogen-free (< 0.25 EU/mL). They eliminate the need to install large, complex water purification systems. They allow for simple dosing and usage, reducing workload on busy ICU staff. Convenient 5-liter bags minimize interventions. • Your choice of solution buffer: Bicarbonate—The body’s natural buffer; may be suitable for patients with lactic acidosis and/or liver failure. The two-compartment bag with unique peel-seam interface simplifies preparation and mixing. Lactate—Simplest, most economical solution; no mixing required. Effectiveness for most patients is well-supported in clinical literature. NxStage PureFlow Solutions for use in acute hemodialysis with the NxStage System One include: Constituent (mEq/L) Lactate Buffer Bicarbonate Buffer RFP-204 RFP-205 RFP-207 RFP-400 RFP-401 RFP-402 RFP-453 RFP-454 Lactate 40 35 45 0 0 0 0 0 Bicarbonate 0 0 0 35 35 35 25 25 Potassium 1 3 1 2 4 0 2 4 Sodium 140 140 140 140 140 140 130 130 Calcium 3 3 3 3 3 3 0 0 Magnesium 1 1 1 1 1 1 1.5 1.5 Chloride 105 112 100 111 113 109 108.5 110.5 Glucose (mg/dL) 100 100 100 100 100 100 100 100 NxStage PureFlow Solutions are indicated for use with renal replacement systems that utilize sterile premixed dialysate. They are not indicated for direct infusion. FLEXIBLE • SAFE • PROTOCOL NEUTRAL Normocarb HF is a pharmaceutical-grade, clinically-tested, FDA approved, protocol-neutral hemofiltration solution for CRRT. • Home • Normocarb o About Normocarb HFFor IntensivistsFor Critical Care NursesFor NephrologistsFor PharmacistsProduct MonographFormulation • Abstracts • Protocols • Links Normocarb HF For Intensivists For Critical Care Nurses For Nephrologists For Pharmacists Contact Sign-up for eNews Your name Your email addre Submit NORMOCARB HF™ Formulation NORMOCARB HF™ is a clear, sterile, nonpyrogenic, electrolyte concentrate used in Continuous Renal Replacement Therapy (CRRT) as a replacement solution in hemofiltration or hemodiafiltration. • H o m e • A b o u t • C o n t a c t Composition Undiluted NORMOCARB HF™ 25 contains 90.73 g/L sodium chloride (NaCl), 2.06 g/L magnesium chloride hexahydrate (MgCl2•6H2O) and 28.35 g/L sodium bicarbonate (NaHCO3) in water for injection. Undiluted NORMOCARB HF™ 35 contains 82.84 g/L sodium chloride (NaCl), 2.06 g/L magnesium chloride hexahydrate (MgCl2•6H2O) and 39.70 g/L sodium bicarbonate (NaHCO3) in water for injection. Diluted NORMOCARB HF™ 25 or NORMOCARB HF™ 35 solutions when prepared as directed, contain the following: NC 25 HF NC 35 HF mEq/L mEq/L Quote "Normocarb HF from the SODIUM (Na) 140.0 140.0 pharmacy eliminates MAGNESIUM (Mg) 1.5 1.5 concerns I have about bedside preparation and CHLORIDE (Cl) 116.5 106.5 solution selection. In our BICARBONATE (HCO3) 25.0 35.0 critical-care environment, we need to put POTASSIUM (K) 0 0 maximum focus on patient care, and on CALCIUM (Ca) 0 0 eliminating errors. pH 8.55 +/- 0.25 8.55 +/- 0.25 Normocarb HF provides me with a safe, flexible solution that I know I can trust." Copyright © 2007 Dialysis Solutions Inc. | All Rights Reserved PrismaSate® Dialysate Easy-to-use dialysate formulas specifically designed for critical care. PrismaSate® dialysate offers six formulas specifically designed for Continuous Renal Replacement Therapy (CRRT). These dialysate formulas save time and expense and provide unmatched prescription flexibility. PrismaSate features: • Sterile, bicarbonate-based solution better controls and corrects acidosis • Each 5-liter, two-compartment bag contains electrolytes and bicarbonate in easy-to-mix solutions that reduce pharmancy labor and the potential for human error • No additional syringes, lines or sterile water needed • • Enables fast and easy bedside preparation and reduced bag changes Includes bar code label to verify that the right formula is being administered to the right patient Legal Notice » © Copyright Gambro Lundia AB, 2007 • • • • • Home Products Intensive Care Products Solutions PrismaSate® Dialysate • • • • • • SUPPORT CENTER PRODUCTS PATIENT RESOURCES CAREERS NEWS CONTACT US PRODUCTS • • In-Center Hemodialysis Products Intensive Care Products o Solutions PrismaSate® Dialysate PrismaSol Replacement Solution o Prismaflex® System o Prisma® System o Other products o FAQ Intensive Care Products o Intensive Care Product Catalog • • Home Sitemap Search PrismaSol Replacement Solution We've done the compounding so you don't have to. PrismaSol replacement solutions, like PrismaSate® dialysate, is commercially produced. This feature, when compared with manual compounding and other solutions that require mixing, assists in the reduction of the complexity and the risk of error. • • • • Sterile bag enables fluid to remain stable for 24 hours after the protective over-wrap is removed and has a 12-month shelf life, ensuring cost-effectiveness and easy storage Pre-mixed 5-liter bag reduces bag changes and eliminates the need for compounding Fast and easy bedside preparation, read-to-mix within the confines of a 2compartment, 5-liter bag Provides both options of a spike port and luer lock port for connecting the replacement fluid line PrismaSol Sterile Hemofiltration and Hemodiafiltration solution PrismaSol solution is a clear, sterile solution free of bacterial endotoxins. This solution is used in Continuous Renal Replacement Therapies (CRRT) as a replacement solution in hemofiltration and hemodiafiltration. It contains no bacteriostatic or antimicrobial agents. PrismaSol is packaged in a two-compartment bag. The small compartment A contains electrolytes and the large compartment B contains buffer. The final reconstituted solution (5000 mL) is obtained after breaking the red frangible pin between compartments A and B and mixing both solutions. The compositions of the solution before and after reconstitution are described in the following tables. Legal Notice » © Copyright Gambro Lundia AB, 2007 • • • • • Home • • • SUPPORT CENTER PRODUCTS PATIENT RESOURCES Products Intensive Care Products Solutions PrismaSol Replacement Solution PrismaSol Replacement Solution We've done the compounding so you don't have to. PrismaSol replacement solutions, like PrismaSate® dialysate, is commercially produced. This feature, when compared with manual compounding and other solutions that require mixing, assists in the reduction of the complexity and the risk of error. • • • • Sterile bag enables fluid to remain stable for 24 hours after the protective over-wrap is removed and has a 12-month shelf life, ensuring cost-effectiveness and easy storage Pre-mixed 5-liter bag reduces bag changes and eliminates the need for compounding Fast and easy bedside preparation, read-to-mix within the confines of a 2compartment, 5-liter bag Provides both options of a spike port and luer lock port for connecting the replacement fluid line PrismaSol Sterile Hemofiltration and Hemodiafiltration solution PrismaSol solution is a clear, sterile solution free of bacterial endotoxins. This solution is used in Continuous Renal Replacement Therapies (CRRT) as a replacement solution in hemofiltration and hemodiafiltration. It contains no bacteriostatic or antimicrobial agents. PrismaSol is packaged in a two-compartment bag. The small compartment A contains electrolytes and the large compartment B contains buffer. The final reconstituted solution (5000 mL) is obtained after breaking the red frangible pin between compartments A and B and mixing both solutions. The compositions of the solution before and after reconstitution are described in the following tables. Legal Notice » © Copyright Gambro Lundia AB, 2007 • • • • • Home • • • • • • SUPPORT CENTER PRODUCTS PATIENT RESOURCES CAREERS NEWS CONTACT US Products Intensive Care Products Solutions PrismaSol Replacement Solution PRODUCTS • • In-Center Hemodialysis Products Intensive Care Products o Solutions PrismaSate® Dialysate PrismaSol Replacement Solution o Prismaflex® System o Prisma® System o Other products o FAQ Intensive Care Products o Intensive Care Product Catalog • • Search Home Sitemap
Similar documents
Current CRRT practices in Canadian Hospitals
regional programs that shared up to 14 machines over several sites. Number of patients per month 33/36 (92%) of sites had 1-10 patients per month. In the 2005 survey, 94% had 1-10 patients per mo...
More information